Calcium Antagonists and Cancer
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 18 (1) , 1-7
- https://doi.org/10.2165/00002018-199818010-00001
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Shanghai trial of nifedipine in the elderlyJournal Of Hypertension, 1996
- Observational studies of drug safetyThe Lancet, 1996
- Calcium antagonists and mortality in patients with coronary artery disease: A Cohort study of 11,575 patientsJournal of the American College of Cardiology, 1996
- Increased Activity of L-Type Ca 2+ Channels Exposed to Serum from Patients with Type I DiabetesScience, 1993
- Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse.1992
- Chronic Calcium Antagonist Use in Carcinoma of the Lung and Colon: A Retrospective Cohort Observational StudyCancer Investigation, 1990
- Calcium Channel Blockers: Potential Antimetastatic AgentsExperimental Biology and Medicine, 1983
- CIRCUMVENTION OF VINCRISTINE AND ADRIAMYCIN RESISTANCE INVITRO AND INVIVO BY CALCIUM INFLUX BLOCKERS1983
- PROMOTION BY VERAPAMIL OF VINCRISTINE RESPONSIVENESS IN TUMOR-CELL LINES INHERENTLY RESISTANT TO THE DRUG1983
- HIGH BLOOD-PRESSURE: A RISK FACTOR FOR CANCER MORTALITY ?The Lancet, 1975